Ocean-Based Climate Solutions Act of 2022 This bill establishes a variety of requirements to reduce carbon emissions and protect oceans, coastal habitats, marine mammals, and fish populations from climate change and other threats.
Environmental Justice For All Act This bill establishes several environmental justice requirements, advisory bodies, and programs and modifies the scope of environmental review under the National Environmental Policy Act of 1969. The bill sets forth provisions to address the disproportionate adverse human health or environmental effects of federal laws or programs on communities of color, low-income communities, or tribal and indigenous communities. It also prohibits disparate impacts on the basis of race, color, or national origin as discrimination. Aggrieved persons may seek legal remedy when faced with such discrimination. In addition, the bill directs agencies to follow certain requirements concerning environmental justice. For example, agencies must prepare community impact reports that assess the potential impacts of their actions on environmental justice communities under certain circumstances. It also raises coal, oil, and gas royalty rates to create a funding source to support fossil fuel-dependent communities and displaced workers as they transition away from fossil fuel industries. Additionally, the bill creates a variety of advisory bodies and positions, such as the White House Environmental Justice Interagency Council. Among other things, the council must issue an environmental justice strategy. It also establishes requirements and programs concerning chemicals or toxic ingredients in certain products. For example, the bill (1) requires certain products (e.g., cosmetics) to include a list of ingredients or warnings; and (2) provides grants for research on designing safer alternatives to chemicals in certain consumer, cleaning, toy, or baby products that have an inherent toxicity or that are associated with chronic adverse health effects. Finally, it creates a variety of funding programs, such as a grant program to enhance access to park and recreational opportunities in urban areas.
Methane Waste Prevention Act of 2021 This bill establishes requirements to reduce methane emissions from the oil and natural gas sector. Methane is emitted during the production and transport of coal, natural gas, and oil. Specifically, the Environmental Protection Agency (EPA) must issue regulations that require the sector to reduce methane emissions over time. By 2025, methane emissions must be at least 65% below 2012 emissions. By 2030, the emissions must be at least 90% below 2012 emissions. The Department of the Interior must also establish regulations to reduce and prevent the waste of natural gas on federal land and Indian lands, including waste from venting, flaring, and fugitive releases. The regulations must include consistent enforcement mechanisms for any oil or gas operations that are not in compliance.
Medical Innovation Act of 2022 This bill requires certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a relevant settlement agreement regarding specified violations must pay 0.75%-1.5% of its net income to the Department of Health and Human Services for each of its covered blockbuster drugs. A covered blockbuster drug is a drug that has at least $1 billion in net sales in a year and was developed, in whole or in part, through federal investments in medical research. Payments are divided between the FDA and the NIH in proportion to the discretionary funding of those agencies, excluding FDA user fees. Payments are not disbursed if appropriations for the FDA or the NIH are lower than in the prior fiscal year. Priorities for payments must include advancing regulatory science for medical products and research related to diseases that disproportionately account for federal health care spending. A covered blockbuster drug for which a manufacturer has not made a required payment is considered misbranded and subject to prohibitions on introducing or receiving misbranded drugs in interstate commerce.
Bus Rapid Transit Act This bill directs the Federal Transit Administration (FTA) to establish a grant program to provide grants to state, local, and tribal governments for the design and implementation of bus rapid transit systems, including for the redesign, retrofit, renovation, update, and repair of existing bus systems. As a condition of receiving a grant, eligible entities must certify that fares for riding the bus rapid transit system shall not increase solely due to improvements carried out with grant funds and for any reason for at least one year after completion of a project funded by the bill. In carrying out the program, the FTA must prioritize projects located in economically disadvantaged communities.
Refugee Protection Act of 2022 This bill modifies provisions related to asylum seekers and addresses related issues. For example, the bill (1) eliminates the statutory time limit for applying for asylum (currently one year after arriving in the United States), (2) establishes stateless protected status for individuals who are not considered a national by any country under that country’s law, and (3) requires the goal for refugee admissions for any given fiscal year to be no fewer than 125,000.
SRES 875 is a non-binding Senate resolution declaring racism a public health crisis in the United States. It directly affects racial and ethnic minority communities, which face documented health disparities including lower life expectancy, higher maternal mortality, and worse pandemic outcomes due to systemic inequities. The resolution commits the Senate to establishing a nationwide strategy to address health disparities, dismantle systemic racism, and advance reforms for communities disproportionately impacted by racism. It cites evidence from public health experts and historical data showing racism meets all criteria of a public health crisis: widespread impact, unfair distribution, preventable nature, and lack of current preventive measures. The resolution is symbolic, urging cross-government action but not creating new laws or funding.
Expanding the Voluntary Opportunities for Translations in Elections Act or the Expanding the VOTE Act This bill expands access to voting materials for individuals with limited proficiency in the English language, including by establishing incentive grants for states and political subdivisions to provide translated voting materials. Additionally, the bill directs the Government Accountability Office to study the impact of (1) reducing the threshold requirement under Section 203 of the Voting Rights Act of 1965, and (2) expanding the definition of language minorities to include native speakers of additional languages.
Medical Innovation Act of 2022 This bill requires certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a relevant settlement agreement regarding specified violations must pay 0.75%-1.5% of its net income to the Department of Health and Human Services for each of its covered blockbuster drugs. A covered blockbuster drug is a drug that has at least $1 billion in net sales in a year and was developed, in whole or in part, through federal investments in medical research. Payments are divided between the FDA and the NIH in proportion to the discretionary funding of those agencies, excluding FDA user fees. Payments are not disbursed if appropriations for the FDA or the NIH are lower than in the prior fiscal year. Priorities for payments must include advancing regulatory science for medical products and research related to diseases that disproportionately account for federal health care spending. A covered blockbuster drug for which a manufacturer has not made a required payment is considered misbranded and subject to prohibitions on introducing or receiving misbranded drugs in interstate commerce.
Promoting a Resolution to the Tibet-China Conflict Act This bill addresses issues relating to Tibet, including by establishing a statutory definition of Tibet that includes areas in Chinese provinces outside the Tibet Autonomous Region (TAR). For the purposes of U.S. policies and activities relating to Tibet, this bill defines Tibet to include the TAR and the Tibetan areas of the Qinghai, Sichuan, Gansu, and Yunnan provinces. (Generally, when China's government refers to Tibet, it means only the TAR, while Tibetan exile groups consider historical Tibet to include the TAR as well as areas in the provinces included in this bill's definition. China's government formally established the TAR in 1965.) Furthermore, the objectives of the Office of the U.S. Special Coordinator for Tibetan Issues shall include working to ensure that U.S. government statements and documents counter disinformation about Tibet by China's government and the Chinese Communist Party, including disinformation about Tibet's history and institutions. The bill also authorizes the office to take other actions to counter such disinformation. This bill also states that it is U.S. policy that the conflict between Tibet and China is unresolved and that Tibet's legal status remains to be determined in accordance with international law.
Stop Arctic Ocean Drilling Act of 2022 This bill limits oil and gas leasing in Arctic areas of the Outer Continental Shelf (OCS). Specifically, the bill prohibits the Department of the Interior from issuing or extending a lease or any other authorization for the exploration, development, or production of oil, natural gas, or any other mineral in Arctic areas of the OCS. In addition, the bill declares that it is the policy of the United States that the Arctic Ocean should be managed for the best interests of the people of the United States, including by keeping fossil fuels in the ground to avoid the dangerous impacts of climate change.
Real Courts, Rule of Law Act of 2022 This bill establishes the U.S. Immigration Courts, a system of courts to be independent of the executive branch. The bill also transfers all functions of the Executive Office for Immigration Review (EOIR) to the Immigration Courts, with some exceptions. (Currently, the EOIR, located in the Department of Justice, has authority to adjudicate immigration cases.) The trial division of the Immigration Courts shall have jurisdiction over various immigration-related matters, including (1) removal proceedings, (2) reviews of rescissions of lawful permanent resident status, and (3) reviews of credible fear determinations in applications for refugee status. The appellate division shall have jurisdiction over appeals of decisions by the trial division and certain Department of Homeland Security determinations. The bill establishes various requirements and authorities relating to the Immigration Courts, including qualifications, length of term in office, and mandatory retirement age for judges. Each appellate division judge must be appointed by the President with the advice and consent of the Senate, and the appellate division shall appoint the trial division judges.
